Chronic Pancreatitis
Gastroenterology·MeSH: Pancreatitis
Prevalence
79.6 / 100K
Incidence
37.0 / 100K/yr
6 drugs in development·6 companies·4 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Creon™ | ABBOTT LABORATORIES (ABT) |
Phase 2(1)
| Drug | Company |
|---|---|
| adrulipase | GridAI Technologies Corp. (GRDX) |
Phase 1(1)
| Drug | Company |
|---|---|
| Simvastatin | UNITED THERAPEUTICS Corp (UTHR) |
Preclinical(1)
| Drug | Company |
|---|---|
| CM6336 | CalciMedica, Inc. (CALC) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| mesenchymal stem cells | GH Research PLC (GHRS) |
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Chronic Pancreatitis?
BioSniper tracks 6 drugs in development for Chronic Pancreatitis across 6 companies.
How many clinical trials target Chronic Pancreatitis?
There are 4 clinical trials targeting Chronic Pancreatitis tracked by BioSniper.
What is the prevalence of Chronic Pancreatitis?
The estimated prevalence of Chronic Pancreatitis is approximately 79.6 per 100,000 population.
Deep-dive into Chronic Pancreatitis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis